Envoy Medical (COCH) Net Margin (2022 - 2026)

Envoy Medical has disclosed Net Margin across 5 years of filings, most recently posting 14258.82% for Q2 2026.

• In Q2 2026, Net Margin fell 535882.0% year-over-year to 14258.82%; the TTM figure through Jun 2026 stood at 13747.34% (down 104284.0% YoY), while the FY2025 annual figure was 11892.95%, up 53950.0% from the prior year.
• Net Margin came in at 14258.82% for Q2 2026 at Envoy Medical, up from 14617.95% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 1750.0% in Q3 2023 to a low of 57385.0% in Q4 2022.
• Average Net Margin over 5 years is 13444.85%, with a median of 13023.91% recorded in 2024.
• Year-over-year, Net Margin surged 5078184 bps in 2023 and tumbled 1485714 bps in 2024.
• Over 5 years, Net Margin stood at 57385.0% in 2022, then jumped by 88 bps to 6603.16% in 2023, then tumbled by 177 bps to 18300.0% in 2024, then surged by 44 bps to 10316.0% in 2025, then sank by 38 bps to 14258.82% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 14258.82% in Q2 2026, 14617.95% in Q1 2026, and 10316.0% in Q4 2025.